Infant and Childhood Neurodevelopmental Outcomes Following Prenatal Exposure to Selective Serotonin Reuptake Inhibitors (SSRIs)

被引:0
|
作者
Malm, Heli [1 ,2 ,3 ,4 ]
Artama, Miia [4 ,5 ]
Brown, Alan S. [6 ,7 ]
Gissler, Mika [4 ,5 ,8 ]
Gyllenberg, David [4 ,9 ]
Hinkka-Yli-Salomaki, Susanna [4 ]
McKeague, Ian [10 ]
Sourander, Andre [4 ,6 ]
机构
[1] HUSLAB, Helsinki, Finland
[2] Univ Helsinki, Dept Clin Pharmacol, SF-00250 Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Helsinki, Finland
[4] Univ Turku, Dept Child Psychiat, Turku, Finland
[5] Natl Inst Hlth & Welf, Helsinki, Finland
[6] Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA
[7] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA
[8] Nord Sch Publ Hlth, Gothenburg, Sweden
[9] Univ Helsinki, Dept Child Psychiat, Helsinki, Finland
[10] Columbia Univ Coll Phys & Surg, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
302
引用
下载
收藏
页码:141 / 142
页数:2
相关论文
共 50 条
  • [1] Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI)
    Malm, Heli
    Artama, Miia
    Brown, Alan S.
    Gissler, Mika
    Gyllenberg, David
    Hinkka-Yli-Salomaki, Susanna
    McKeague, Ian
    Sourander, Andre
    BMC PSYCHIATRY, 2012, 12
  • [2] Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI)
    Heli Malm
    Miia Artama
    Alan S Brown
    Mika Gissler
    David Gyllenberg
    Susanna Hinkka-Yli-Salomäki
    Ian McKeague
    Andre Sourander
    BMC Psychiatry, 12
  • [3] Prenatal Exposure to Selective Serotonin Reuptake Inhibitors and Infant Outcome
    Malm, Heli
    THERAPEUTIC DRUG MONITORING, 2012, 34 (06) : 607 - 614
  • [4] Selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors in pregnancy: Infant and childhood outcomes
    Hendson, Leonora
    Shah, Vibhuti
    Trkulja, Sandra
    PAEDIATRICS & CHILD HEALTH, 2021, 26 (05) : 321 - 321
  • [5] Prenatal exposure to selective serotonin reuptake inhibitors and risk of childhood overweight
    Grzeskowiak, L. E.
    Gilbert, A. L.
    Morrison, J. L.
    JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, 2012, 3 (04) : 253 - 261
  • [6] Selective serotonin reuptake inhibitors (SSRIS) and adverse pregnancy outcomes
    Wen, SW
    Yang, QY
    Garner, P
    Fraser, W
    Olatunbosun, O
    Nimrod, C
    Walker, M
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (06) : S36 - S36
  • [7] Serotonin Selective Reuptake Inhibitors (SSRIs) and Stroke
    Chollet, F.
    Rigal, J.
    Marque, P.
    Barbieux-Guillot, M.
    Raposo, N.
    Fabry, V.
    Albucher, J. F.
    Pariente, J.
    Loubinoux, I.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (12)
  • [8] Selective serotonin reuptake inhibitors antidepressants (SSRIs)
    Chavez-Leon, Enrique
    Ontiveros Uribe, Martha Patricia
    Gomez, Carlos Serrano
    SALUD MENTAL, 2008, 31 (04) : 307 - 319
  • [9] Serotonin Selective Reuptake Inhibitors (SSRIs) and Stroke
    F. Chollet
    J. Rigal
    P. Marque
    M. Barbieux-Guillot
    N. Raposo
    V. Fabry
    J. F. Albucher
    J. Pariente
    I. Loubinoux
    Current Neurology and Neuroscience Reports, 2018, 18